Innovative Diagnostics is a science-based company: our R&D activities ensure that our products reflect the cutting-edge of RT-PCR and ELISA technology, and allow us to continuously launch new, innovative tests.

We remain at the forefront of infectious disease diagnostics by:

• Re-investing 30% of turnover in R&D projects
• Building close relationships with leading scientists and reference laboratories worldwide
• Participating in European research programs
• Participating in normalization programs